AC Immune stock jumps 20% on data for Parkinson's disease drug
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
Nottinghamshire Live on MSN6h
Nightmares could be a symptom of serious illnesses like Parkinson's or heart problems
Nightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
AC Immune’s Promising Trial Results for Parkinson’s Therapy
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
ScienceAlert9h
Not Just Weight Loss: 8 Conditions Drugs Like Wegovy Might Treat
There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...
Nanowerk20h
Nanodiamonds bring new hope for Parkinson's research with advanced neuronal sensing
Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...
The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Frontiers2h
Molecular Mechanisms and Therapeutic Strategies of Head and Neck Disease
Head and neck diseases contain tumors, infections, inflammation, and other lesions. These diseases often involve tissues in the mouth, throat, larynx, nasal cavity, paranasal sinuses, ears, and neck.